Subscribe
3 July 2025NewsEuropeTom Phillips

‘We created law’: G1/24 and the creation of the ‘diamond standard’

The architect of an historic change in the way patent claims are interpreted explains what it means for AI drafting, and why more harmonisation may follow, reports Tom Phillips.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Europe
Broad Institute wins appeal to restore CRISPR patent in Europe
26 June 2025   Biotech institute successfully challenges EPO decision revoking key CRISPR patent over priority rights | Appeal follows major changes to European law | Case returns to lower court for novelty and inventive step evaluation.
Europe
UPC rejects Alexion’s rehearing bid in spat with Amgen and Samsung
20 June 2025   Court sets strict rules on rehearing's, saying "only fundamental procedural defects can be the basis for a rehearing” | Follows UK blow to Alexion, allowing biosimilars onto market.


Editor's picks

BMS blocks biosimilar version of blockbuster cancer drug in India
Americas
BMS blocks biosimilar version of blockbuster cancer drug in India
21 July 2025

Editor's picks

Americas
BMS blocks biosimilar version of blockbuster cancer drug in India
21 July 2025
Africa
Explainer: ARIPO’s role in Plant Variety Protection
15 July 2025
Europe
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025
Americas
Bankruptcy judge approves $305m sale of genetics testing company
1 July 2025
Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025
Europe
Diverging in the detail: UPC local divisions and Court of Appeal take different paths
19 June 2025

More on this story

Europe
Broad Institute wins appeal to restore CRISPR patent in Europe
26 June 2025   Biotech institute successfully challenges EPO decision revoking key CRISPR patent over priority rights | Appeal follows major changes to European law | Case returns to lower court for novelty and inventive step evaluation.
Europe
UPC rejects Alexion’s rehearing bid in spat with Amgen and Samsung
20 June 2025   Court sets strict rules on rehearing's, saying "only fundamental procedural defects can be the basis for a rehearing” | Follows UK blow to Alexion, allowing biosimilars onto market.

More on this story

Europe
Broad Institute wins appeal to restore CRISPR patent in Europe
26 June 2025   Biotech institute successfully challenges EPO decision revoking key CRISPR patent over priority rights | Appeal follows major changes to European law | Case returns to lower court for novelty and inventive step evaluation.
Europe
UPC rejects Alexion’s rehearing bid in spat with Amgen and Samsung
20 June 2025   Court sets strict rules on rehearing's, saying "only fundamental procedural defects can be the basis for a rehearing” | Follows UK blow to Alexion, allowing biosimilars onto market.

More features

UPC hands rare default win to Insulet, bans insulin pump in EU
GSK loses appeal over purple inhaler TM in Europe
Astellas defends Xtandi patent as court rejects generics’ appeal
Jury sides with Allergan in $56M Botox tech feud
Novartis fails latest bid to block Entresto copies
BMS blocks biosimilar version of blockbuster cancer drug in India
WATCH: Protecting life science innovations involving big data, AI and machine learning
AbbVie blocks Humira antitrust suit